Treatment of Premature Ejaculation with Unani Medicine Majoon-e-Piyaz

Phase 2

Not yet recruiting

• Conditions: Surat Inzaal (Premature Ejaculation); Unspecified male sexual dysfunction,

• Registration Number: CTRI/2018/08/015405
• Lead Sponsor: Central Council For Research In Unani Medicine

Brief Summary

This study is  a multicentric open trial in patients with **Surat Inzaal (Premature Ejaculation)** After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically at weekly.  This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 2 weeks. . Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy.

**Compositionof*****Majoon -e- Piyaz******:***

| | | | |

| --- | --- | --- | --- |

|**S. No.**

**Ingredients**

**Botanical / Chemical Name**

**Quantity**

|1.

Tudri Surkh

*Mathiola incana*

35 g

|2.

Tudri Safaid

35 g

|3.

Salab Misri

*Orchis latifolia*

35g

|4.

Behman Surkh

*Salvia haematodes*

35 g

|5.

Behman Safaid

*Centaurea behman*

35 g

|6.

Zanjabeel

*Zingiber officinale*

35 g

|7.

Tukhm-e-Piyaz

*Allium cepa*

35 g

|8.

Tukhm-e-Turb

*Raphanus sativus*

35 g

|9.

Tukhm-e-Gandana

*Alliumascalonicum*

35 g

|10.

Tukhm-e-Shalgham

*Brassia rapa*

35g

|11.

Talmakhana

*Asteracanthna longifolia*

35g

|12.

Musli Safaid

*Chlorophytum arundinaceum*

35g

|13.

Musli Siyiah

*Curculigo orchioides*

35g

|15.

Aab-e-Piyaz

*Allium cepa* (aqueous Extract)

1.5 litter

|16.

Asal/Quand Safaid

 1.5kg

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2018-07-12
• Study Start: 2018-08-23

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

• The following criteria will be strictly followed for inclusion of cases in the study.
• Male patients in the age group of 21 to 65 years.
• Men with an IELT ( Intra-vaginal ejaculatory latency time) of less than 1 minute will be included in the study 3.
• Men with a PEDT Score >11.

Exclusion Criteria

• The patients of Surat-e-Inzal (Premature ejaculation) with following conditions will be excluded from the study: 1.
• Patients with Erectile Dysfunction 2.
• Patients with diseases requiring long term treatment 3.
• Patients with cognitive impairments 4.
• History of addiction (smoking, alcohol, drugs).

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in the sign and symptoms of NisyÄn (Amnesia)	Two Weeks

Secondary Outcome Measures

Name	Time	Method
Hematological and biochemical assessments for safety	2 weeks

Trial Locations

Locations (2)

Central Research Institute of Unani Medicine; 🇮🇳 Lucknow, UTTAR PRADESH, India

Clinical Research Unit; 🇮🇳 Nimar, MADHYA PRADESH, India

Central Research Institute of Unani Medicine

🇮🇳Lucknow, UTTAR PRADESH, India

Dr Shamsul Arfin

Principal investigator

9450389873

crium_lko@yahoo.co.in